| 000 | 01568 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514233545.0 | ||
| 264 | 0 | _c20050915 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a1042-8194 | ||
| 024 | 7 |
_a10.1080/10428190400028959 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZeitlinger, M A | |
| 245 | 0 | 0 |
_aEffective treatment of a peripheral T-cell lymphoma/lymphoepitheloid cell variant (Lennert's lymphoma) refractory to chemotherapy with the CD-52 antibody alemtuzumab. _h[electronic resource] |
| 260 |
_bLeukemia & lymphoma _cMay 2005 |
||
| 300 |
_a771-4 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAlemtuzumab |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntibodies, Neoplasm _xtherapeutic use |
| 650 | 0 | 4 |
_aAntigens, CD _ximmunology |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCD52 Antigen |
| 650 | 0 | 4 |
_aGlycoproteins _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aLymphoma, T-Cell, Peripheral _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 700 | 1 | _aSchmidinger, M | |
| 700 | 1 | _aZielinski, C C | |
| 700 | 1 | _aChott, A | |
| 700 | 1 | _aRaderer, M | |
| 773 | 0 |
_tLeukemia & lymphoma _gvol. 46 _gno. 5 _gp. 771-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10428190400028959 _zAvailable from publisher's website |
| 999 |
_c15675005 _d15675005 |
||